Cargando…

Effectiveness of a computerized clinical decision support system for prevention of glucocorticoid-induced osteoporosis

Glucocorticoids are widely used for a variety of diseases, but the prevention of glucocorticoid-induced osteoporosis is sometimes neglected. Therefore, the effectiveness of a computerized clinical decision support system (CDSS) to improve the performance rate of preventive care for glucocorticoid-in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Morikawa, Toru, Sakuma, Mio, Nakamura, Tsukasa, Sonoyama, Tomohiro, Matsumoto, Chisa, Takeuchi, Jiro, Ohta, Yoshinori, Kosaka, Shinji, Morimoto, Takeshi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9440130/ https://www.ncbi.nlm.nih.gov/pubmed/36056121 http://dx.doi.org/10.1038/s41598-022-19079-7

Ejemplares similares

Clinical Decision Support System with Renal Dose Adjustment Did Not Improve Subsequent Renal and Hepatic Function among Inpatients: The Japan Adverse Drug Event Study
por: Wada, Ryuhei, et al.
Publicado: (2020)

Association between heart rate on admission and in-hospital mortality among general inpatients: Insights from Japan Adverse Drug Events (JADE) study
por: Yamamoto, Marumi, et al.
Publicado: (2019)

Low Serum Total Protein at Admission Predicts in-Hospital Mortality Among General Inpatients: Historical Cohort Study
por: Inoue, Miharu, et al.
Publicado: (2022)

Differences in Adverse Drug Events Among Pediatric Patients With and Without Cancer: Sub-Analysis of a Retrospective Cohort Study
por: Koizumi, Akira, et al.
Publicado: (2017)

Experience and awareness of research integrity among Japanese physicians: a nationwide cross-sectional study
por: Nishimura, Rie, et al.
Publicado: (2021)

Epidemiology of Adverse Events and Medical Errors in the Care of Cardiology Patients
por: Ohta, Yoshinori, et al.
Publicado: (2019)

Glucocorticoid-induced osteoporosis
por: Briot, Karine, et al.
Publicado: (2015)

Glucocorticoid-induced Osteoporosis
por: Cherian, Kripa Elizabeth, et al.
Publicado: (2017)

Advances in Glucocorticoid-Induced Osteoporosis
por: den Uyl, Debby, et al.
Publicado: (2011)

Mechanisms of glucocorticoid induced osteoporosis
por: Canalis, E
Publicado: (2004)

Glucocorticoid-induced osteoporosis: an update
por: Compston, Juliet
Publicado: (2018)

Update on Glucocorticoid Induced Osteoporosis
por: Cho, Soo-Kyung, et al.
Publicado: (2021)

Incidence of atrial fibrillation in elderly patients with type 2 diabetes mellitus
por: Matsumoto, Chisa, et al.
Publicado: (2022)

Glucocorticoid‐induced osteoporosis in rheumatic diseases
por: Pereira, Rosa Maria Rodrigues, et al.
Publicado: (2010)

Bisphosphonates and glucocorticoid-induced osteoporosis: cons
por: Lems, Willem F., et al.
Publicado: (2015)

Linking glucocorticoid-induced osteoporosis to osteoimmunology
por: von Gunten, Stephan, et al.
Publicado: (2020)

Zebrafish models for glucocorticoid-induced osteoporosis
por: Lin, Wen-Ying, et al.
Publicado: (2022)

Management of glucocorticoids-induced osteoporosis: role of teriparatide
por: Migliaccio, Silvia, et al.
Publicado: (2009)

Role of teriparatide in treatment of glucocorticoid-induced osteoporosis
por: Lau, Arthur N, et al.
Publicado: (2010)

The Efficacy of Minodronate in the Treatment of Glucocorticoid-induced Osteoporosis
por: Hasegawa, Eriko, et al.
Publicado: (2018)

Glucocorticoid-Induced Osteoporosis: Why Kids Are Different
por: Ward, Leanne M.
Publicado: (2020)

The critical role of T cells in glucocorticoid-induced osteoporosis
por: Song, Lin, et al.
Publicado: (2020)

The molecular etiology and treatment of glucocorticoid-induced osteoporosis
por: Peng, Cheng-Huan, et al.
Publicado: (2021)

Improving the assessment of adverse drug reactions using the Naranjo Algorithm in daily practice: The Japan Adverse Drug Events Study
por: Murayama, Hiroki, et al.
Publicado: (2018)

The Burden of Preventable Adverse Drug Events on Hospital Stay and Healthcare Costs in Japanese Pediatric Inpatients: The JADE Study
por: Iwasaki, Hitoshi, et al.
Publicado: (2021)

Association Between Active Gait Training for Severely Disabled Patients with Nasogastric Tube Feeding or Gastrostoma and Recovery of Oral Feeding: A Retrospective Cohort Study
por: Arai, Hideki, et al.
Publicado: (2020)

Osteoporosis prophylaxis in patients receiving chronic glucocorticoid therapy
por: Sadat-Ali, Mir, et al.
Publicado: (2009)

Glucocorticoid-Induced Osteoporosis in Children with 21-Hydroxylase Deficiency
por: Ventura, Annamaria, et al.
Publicado: (2013)

Korean Guideline for the Prevention and Treatment of Glucocorticoid-induced Osteoporosis
por: Park, So Young, et al.
Publicado: (2018)

The Use of Herbal Medicines for the Prevention of Glucocorticoid-Induced Osteoporosis
por: Zhang, Leiming, et al.
Publicado: (2021)

Pharmacological Interventions for Glucocorticoid-Induced Osteoporosis: An Umbrella Review
por: Liang, Haodong, et al.
Publicado: (2023)

Galangin mitigates glucocorticoid-induced osteoporosis by activating autophagy of BMSCs via triggering the PKA/CREB signaling pathway: Galangin mitigates glucocorticoid-induced osteoporosis
por: Zeng, Chenying, et al.
Publicado: (2023)

Randomized Evaluation of Anagliptin vs Sitagliptin On low-density lipoproteiN cholesterol in diabetes (REASON) Trial: A 52-week, open-label, randomized clinical trial
por: Morimoto, Takeshi, et al.
Publicado: (2019)

Author Correction: Randomized Evaluation of Anagliptin vs Sitagliptin On low-density lipoproteiN cholesterol in diabetes (REASON) Trial: A 52-week, open-label, randomized clinical trial
por: Morimoto, Takeshi, et al.
Publicado: (2020)

Management of glucocorticoid-induced osteoporosis: prevalence, and emerging treatment options
por: Payer, Juraj, et al.
Publicado: (2010)

Characterization of a rabbit osteoporosis model induced by ovariectomy and glucocorticoid
por: Baofeng, Li, et al.
Publicado: (2010)

Efficacy and safety of zoledronic acid in the treatment of glucocorticoid-induced osteoporosis
por: Serefoglu, Ege Can, et al.
Publicado: (2010)

Glucocorticoid-Induced Osteoporosis – A Disorder of Mesenchymal Stromal Cells?
por: Hardy, Rowan, et al.
Publicado: (2011)

Regulation of sclerostin in glucocorticoid-induced osteoporosis (GIO) in mice and humans
por: Thiele, Sylvia, et al.
Publicado: (2019)

Preventive effects of Polygonum multiflorum on glucocorticoid-induced osteoporosis in rats
por: Zhou, Manru, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_uishvc4fvi85k0c24ddbi9ueuo